COL6A1 and Bethlem myopathy: Whole exome sequencing (WES) subsequently identified a heterozygous pathogenic splice-site variant (c.1056+1G>A) in the COL6A1 gene, confirming a diagnosis of Bethlem myopathy type 1, an autosomal dominant collagen VI-related disorder.